BEUDAMED
    7 results · 7ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters FDA Classification × Classification: FDA Class 3 × Clear all

    Somatic Gene Mutation Detection System

    FDA classification
    FDA Class 3 ·Somatic Gene Mutation Detection System

    Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled

    FDA classification
    FDA Class 3 ·Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled

    Cancer-Related Germline Gene Mutation Detection System

    FDA classification
    FDA Class 3 ·Cancer-Related Germline Gene Mutation Detection System

    Prostrate Cancer Genes Nucleic Acid Amplification Test System

    FDA classification
    FDA Class 3 ·Prostrate Cancer Genes Nucleic Acid Amplification Test System

    Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement

    FDA classification
    FDA Class 3 ·Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement

    Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion

    FDA classification
    FDA Class 3 ·Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA classification
    FDA Class 3 ·Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer